Remedis (WSE:REM) - Stock Price, News & Analysis

REM Stock Overview

Remedis SA provides financial management services to health care institutions and local government units. More details

REM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Risk Analysis

Earnings have declined by 31% per year over past 5 years

Does not have a meaningful market cap (PLN5M)

Makes less than USD$1m in revenue (PLN-769K)

Shares are highly illiquid

+ 1 more risk

Remedis SA Competitors

Capitea

WSE:CAP

zł44.9m

Devo Energy

WSE:EGY

zł4.3m

ABS Investment ASI

WSE:AIN

zł5.2m

Pragma Inkaso

WSE:PRI

zł14.3m

Price History & Performance

Summary of all time highs, changes and price drops for Remedis
Historical stock prices
Current Share Price	zł0.08
52 Week High	zł0.09
52 Week Low	zł0.04
Beta	1.0
11 Month Change	0%
3 Month Change	-11.11%
1 Year Change	100.00%
33 Year Change	-41.61%
5 Year Change	166.67%
Change since IPO	-91.11%

Recent updates

Shareholder Returns

	REM	PL Diversified Financial	PL Market
7D	0%	-1.4%	-3.1%
1Y	100.0%	-15.8%	-1.7%

Return vs Industry: REM exceeded the Polish Diversified Financial industry which returned 25.1% over the past year.

Return vs Market: REM exceeded the Polish Market which returned 24.7% over the past year.

Price Volatility

Is REM's price volatile compared to industry and market?
REM volatility
REM Average Weekly Movement	n/a
Diversified Financial Industry Average Movement	4.0%
Market Average Movement	4.8%
10% most volatile stocks in PL Market	8.6%
10% least volatile stocks in PL Market	3.0%

Stable Share Price: REM has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine REM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	3	Marcin Wyszogrodzki	remedis.eu

Remedis SA provides financial management services to health care institutions and local government units. It offers financing, capital investment, consultancy, and restructuring services. The company is based in Poznan, Poland.

Remedis SA Fundamentals Summary

How do Remedis's earnings and revenue compare to its market cap?
REM fundamental statistics
Market cap	zł5.06m
Earnings (TTM)	-zł2.32m
Revenue (TTM)	n/a

-6.6x

P/S Ratio

-2.2x

P/E Ratio

Is REM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
REM income statement (TTM)
Revenue	-zł769.09k
Cost of Revenue	zł712.00
Gross Profit	-zł769.80k
Other Expenses	zł1.55m
Earnings	-zł2.32m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

Nov 10, 2023

Earnings per share (EPS)	-0.037
Gross Margin	100.09%
Net Profit Margin	301.03%
Debt/Equity Ratio	3,397.0%

How did REM perform over the long term?

See historical performance and comparison

Remedis WSE:REM Stock Report